Rocket Lab (NASDAQ: RKLB) has posted one-year revenue growth of 45.8%, cementing its place among the most compelling growth stories in the aerospace sector. Halozyme Therapeutics (NASDAQ: HALO) is another standout, having delivered one-year revenue growth of 39.1% on the back of its proprietary ENHANZE drug-delivery platform. Happen Bank (NYSE: HAPN), which pioneered peer-to-peer lending in the United States before evolving into a full digital banking platform, rounds out the trio with one-year revenue growth of 18.4%. Happen Bank has sustained annual revenue growth of 18.1% over the past five years, a consistent record that suggests durable competitive positioning rather than a cyclical spike. Happen Bank shares trade at $19.10, representing a forward price-to-earnings multiple of 9.9x, a valuation that appears modest given the company’s demonstrated earnings momentum.